Ursodeoxycholic acid for sepsis: a study on reducing inflammation
Treatments studied
Part of Infections clinical trials.
This trial tests whether adding ursodeoxycholic acid (a bile acid supplement) to standard sepsis treatment can reduce inflammation and organ damage. It aims to improve recovery in adults with sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed or suspected infection (bacterial, viral, or fungal).
- You must have been diagnosed with sepsis by a doctor.
- You must not be allergic to ursodeoxycholic acid.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This trial studies whether early tranexamic acid (a medicine that can reduce bleeding) can change the body’s inflammatory response in people with sepsis. If it works, it may help improve outcomes for certain ICU patients—but you must meet specific safety and eligibility checks.
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
This trial is testing several different treatments to find the best one for each person with sepsis. It looks at specific 'treatable traits' like inflammation, blood clotting problems, or immune system issues to match you with the right therapy. The goal is to improve recovery and survival.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.